Skip to main content

Pharmaceutical Quality Control

November 20, 2024

Advancing Antimicrobial Stewardship in Emergency Care: how diagnostics can change the game.

Antimicrobial resistance (AMR) has been identified as an increasing threat to modern medicine, leading to higher treatment costs and increased morbidity and mortality.1 The misuse of broad-spectrum antibiotics is a major contributor to the rise of AMR — particularly in emergency care, where studies have estimated that 40% to 60% of antibiotics are inappropriately prescribed.2 To understand the cause of this disparity, it is important to provide context on the many unique facets of the emergency department, while exploring how comprehensive antimicrobial stewardship could improve prescribing practices.
Discover More

  • March 26, 2024

    Precision matters: Navigating the landscape of quality control in biologics

    Humans have been using plant and animal derived products (biologics) to treat disease for thousands of years, but the advent of mass production in the 20th century enabled the growth of biologics as a recognized class of medicines. Unlike chemically derived medicines, which combine specific ingredients in an ordered process, biologics are typically very large, complex molecules or mixtures of molecules that are difficult to characterize.
    Read more

  • January 17, 2024

    Addressing Challenges in Expanding Access to Cell & Gene Therapies

    Cell and gene therapies have been undergoing exciting developments recently, including expansion into second line use for existing products. This means that cell and gene therapies are no longer treatments of last resort, and studies are currently underway for front line use.
    Read more

  • January 03, 2024

    Collaborative Research and Quality Control Supports Cell & Gene Therapy Development & Manufacturing

    The landscape of advanced therapy medicinal products (ATMPs) continues to evolve rapidly, revolutionizing modern medicine to help provide additional treatment options for patients with rare diseases, cancers, and autoimmune disorders.
    Read more

  • December 20, 2023

    Evolution of Cell and Gene Therapies and the Role of Rapid Quality Control Solutions to Ensure Safe and Effective Products

    Cell, gene, and tissue-based therapies, also referred to as Advanced Therapy Medicinal Products (ATMPs), present unique opportunities to address some of the most problematic diseases, like cancer autoimmune diseases, cardiac diseases, etc., including those with limited treatment options and genetic disorders such as cystic fibrosis, thalassemia, hemophilia, and sickle cell disease.
    Read more